CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Second Line Therapy in Autoimmune Hepatitis: is Mycophenolate Mofetil an effective option?
DOI 10.1055/s-0032-1332020
Bibliografische Angaben
Nachweis in CareLit
Autor:innenPS Ploch, JU Marquardt, S Fritzsche, M Krupp, PR Galle, A Teufel, AP Barreiros
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2013
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Autoimmune hepatitis (AIH) has a good prognosis when the inflammatory reaction is sufficiently suppressed and the development of cirrhosis is prevented. Steroids and Azathioprin (AZA) are established for first-line-therapy. However, there is no established regimen in case of ineffectiveness of this combination. Results from a small study suggest Mycophenolate Mofetil (MMF) to be effective in patients with AZA intole…
Zitieren
Zitierempfehlung
PS Ploch, JU Marquardt, S Fritzsche, M Krupp, PR Galle, A Teufel, AP Barreiros (2013) Second Line Therapy in Autoimmune Hepatitis: is Mycophenolate Mofetil an effective option?. Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0032-1332020
Mit CareLit weiterarbeiten